Wyeth Ceases Production of its Injectable Influenza Vaccine and Pneumococcal Polysaccharide Vaccine
MADISON N.J. -- Wyeth has announced it is ceasing production of two of its vaccine products -- FluShield, an injectable influenza virus vaccine and Pnu-Imune, an injectable polysaccharide pneumococcal vaccine for adults. Adequate supplies of injectable flu vaccine are now available in the U.S. as a result of recent capacity increases provided by other manufacturers.
In addition, Wyeth has chosen to pursue new flu immunization technologies - specifically through its partnership with MedImmune to develop and market FluMist, an intranasal influenza vaccine. The focus on developing new vaccine products should result in better choices for physicians and patients, but requires a reallocation of company resources.
Wyeth is making this announcement now, well in advance of the 2003-2004 season, to give those companies remaining in the marketplace sufficient time to prepare and produce vaccine for the next season.
Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
